Skip to main content
. Author manuscript; available in PMC: 2010 May 14.
Published in final edited form as: Drug Test Anal. 2009 Sep;1(9-10):447–454. doi: 10.1002/dta.96

Table 3.

Human Growth Hormone was measured in blood and urine at the same time from healthy donors.

Healthy Donor

hGH +
Blood

(ng/ml)
Direct Measurement in
Urine by the
Immunoassay
(ng/ml)
Particle

Eluate
(ng/ml)
Calculated actual urine concentration of

hGH following nanoparticles harvesting
(Particle Eluate / Concentration Factor)
(pg/ml)
1 2.830 <0.050 0.107 0.973
2 0.095 <0.050 0.056 0.509
3 10.136 <0.050 0.078 0.100
4 1.880 <0.050 0.058 0.527
4 repeat 2.04 <0.050 0.063 0.572
+

Measurements were done using the Immulite hGH serum Immunoassay (Siemens) with a lower detection limit of 50 pg/ml and a linear range of 50 pg-40 ng per ml.

Prior to nanoparticle sequestration of hGH from the urine, the concentration of hGH in all urine samples was below the detection limit (<0.050 ng/mL) of the immulite assay.

The actual concentration in urine was calculated as (particle eluate concentration) / CF, where CF is the Concentration Factor = (Starting volume of urine) / (Volume of eluate) = 33ml/0.3 ml = 110.